Tandem Diabetes Care: Q3 Earnings Insights

Tandem Diabetes Care TNDM reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Tandem Diabetes Care their estimated earnings by 50.0%, reporting an EPS of $0.09 versus an estimate of $0.06, which surprised analysts.

Revenue was up $56,024,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.14, which was followed by a 4.73% increase in the share price the next day.

Here's a look at Tandem Diabetes Care's past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.08 -0.16 0.12 -0.10
EPS Actual 0.06 -0.08 0.22 -0.15
Revenue Estimate 143.63M 121.96M 141.58M 115.15M
Revenue Actual 172.14M 141.04M 168.06M 123.60M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

TNDM Logo
TNDMTandem Diabetes Care Inc
$23.13-%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
14.38
Growth
1.58
Quality
-
Value
52.33
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...